-
BAPTA and the Calcium-Controlled Toxicity Switch
2026-09-15
BAPTA is more than a calcium chelator: used as a causal perturbation tool, it can help translational researchers distinguish calcium-driven apoptosis from downstream correlation. This article interprets recent nanoplastic–cadmium findings, outlines a study-aligned workflow, and explains how BAPTA supports stronger environmental toxicology and cell signaling studies.
-
VX-661: F508del CFTR Corrector Guide
2026-09-14
VX-661 is a small-molecule F508del CFTR corrector that supports mutant-protein folding, trafficking, and cell-surface expression in cystic fibrosis research. Product and peer-reviewed evidence support its use as a corrector-focused tool that is mechanistically distinct from the potentiator VX-770.
-
RESTRICT-seq Maps Epigenetic Dependencies in SCC Resistance
2026-09-14
The reference preprint introduces RESTRICT-seq, a time-gated CRISPR screening strategy designed to distinguish early drivers of squamous cell carcinoma resistance from dependencies that sustain the resistant state. Its identification of KAT6A as an epigenetic vulnerability provides a framework for studying resistance-associated cell-state regulation and prioritizing mechanistic follow-up experiments.
-
Shaped ABC Coil-Bottlebrush Terpolymer Self-Assembly
2026-09-13
This study examines how digitally shaped bottlebrush blocks and block sequence influence phase behavior in ABC coil-bottlebrush terpolymers. SAXS showed robust microphase separation but systematic suppression of double-gyroid formation and unexpectedly slow structural ordering, providing important design constraints for large-period network materials.
-
2X HyperFusion High-Fidelity Master Mix for CRISPR
2026-09-12
Discover how the 2X HyperFusion High-Fidelity Master Mix supports accurate PCR in CRISPR-enabled oncology research. This article connects a recent bufalin–CRISPR nanomedicine study to practical assay design, construct verification, and fidelity-driven workflow decisions.
-
FK866 (APO866): Turning NAD Depletion into Insight
2026-09-11
A mechanistic and translational framework for using FK866 (APO866) to study NAMPT dependence, NAD depletion, mitochondrial stress, and therapeutic vulnerability across hematologic cancer research, with a carefully bounded connection to PARP inhibitor resistance in ovarian cancer.
-
Dihydroartemisinin: From Mechanism to Translation
2026-09-11
Dihydroartemisinin is more than a familiar antimalarial scaffold. Its mTOR-linked effects on cell proliferation, antipsoriasis and anti-inflammatory research relevance, and defined formulation profile make it a useful translational benchmark. This article explains how to position the compound alongside emerging antiplasmodial strategies such as phebestin while keeping evidence, experimental design, and development maturity clearly separated.
-
Phenothiazines, ROS, and Macrophage Antibacterial Defense
2026-09-10
Qiu et al. report that phenothiazines strengthen macrophage control of intracellular bacteria by increasing reactive oxygen species, lysosomal activity, and autophagy. The study positions perphenazine as a host-directed antibacterial lead while showing that pharmacological disruption of ROS or autophagy reduces the protective phenotype.
-
mRNA-LNP Programming of CAR Macrophages
2026-09-10
Gu et al. develop a macrophage-targeted mRNA lipid nanoparticle system for intraperitoneal programming of chimeric antigen receptor macrophages and compare 36 CAR formats. The study identifies CD3ζ–TLR4 intracellular domains as a tailored design that reshapes the tumor microenvironment, expands TCF1+PD-1+ progenitor-exhausted CD8+ T cells, and improves responses to PD-1/L1 therapy.
-
PRDX5 Acetylation in Retinal Ischemia-Reperfusion
2026-09-09
The reference study identifies PRDX5 acetylation as a regulatory event that weakens antioxidant and anti-apoptotic protection during retinal ischemia-reperfusion injury. Using an acute high-intraocular-pressure mouse model and OGD/R-treated R28 cells, the authors connect PRDX5 abundance and acetylation status with oxidative stress, mitochondrial dysfunction, and neuronal apoptosis, providing a mechanistic framework for follow-up studies.
-
Coke Oven Emissions, Ferroptosis, and Allergic Asthma
2026-09-09
This study provides experimental evidence that coke oven emissions intensify house dust mite–induced allergic asthma in mice and identifies ferroptosis in airway epithelial cells as a mechanistic link. Its combined exposure, iron-chelation, and 3-MA intervention design connects environmental pollution with iron-dependent cell death and suggests a framework for studying pollutant-aggravated airway disease.
-
ECL Chemiluminescent Substrate Detection Kit Guide
2026-09-08
Learn how to use a hypersensitive ECL workflow for immunoblotting detection of low-abundance proteins, from membrane preparation through exposure optimization. The approach combines low-background horseradish peroxidase chemiluminescence with practical assay controls, pathway-focused applications, and troubleshooting for nitrocellulose and PVDF membranes.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-09-08
2-Hydroxypropyl-β-cyclodextrin is a cyclic oligosaccharide solubilizer for poorly water-soluble, hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. This guide focuses on drug formulation excipient and pharmaceutical solubility improvement workflows; no directly matched paper evidence is available in the supplied material for broader applications.
-
2-NBDG: From Uptake Signal to Mechanism
2026-09-07
2-NBDG can turn a broad glucose-uptake phenotype into a cell-resolved mechanistic assay. This article explains how to apply it to natural-product and diabetes research while distinguishing transporter activity, intracellular trapping, and true metabolic flux.
-
Deferoxamine Mesylate in Lysosomal Stress Biology
2026-09-07
Deferoxamine mesylate offers a mechanistically useful way to interrogate iron availability, hypoxia signaling, and lysosomal stress. This article translates a 2025 Cell Reports study into practical assay decisions without treating iron chelation as a substitute for genetic pathway analysis.